Winzenrieth, R. http://orcid.org/0000-0002-2755-6063
Ominsky, M.S. http://orcid.org/0000-0002-9563-414X
Wang, Y. http://orcid.org/0000-0002-5741-9836
Humbert, L. http://orcid.org/0000-0002-3675-7908
Weiss, R.J. http://orcid.org/0000-0002-0095-2410
Funding for this research was provided by:
Radius Health Inc
Article History
Received: 22 September 2020
Accepted: 17 December 2020
First Online: 26 January 2021
Compliance with ethical standards
:
: RW and LH are employees of Galgo Medical and paid consultants of Radius. LH is a shareholder of Galgo Medical. MSO, YW, and RJW are employees and shareholders of Radius.
: The ACTIVE study on which this post hoc analysis was based was conducted in accordance with the ethical principles in the Declaration of Helsinki in its revised edition (Tokyo, 2004), the guidelines for current Good Clinical Practice (GCP), and the ACTIVE trial was approved by the appropriate ethics and institutional review boards.
: Written informed consent was obtained from each patient participating in the ACTIVE study on which this post hoc analysis is based.
: For this post hoc analysis study, formal consent is not required.
: 3D-DXAsoftware (v2.10.1, Galgo Medical, Spain)